Institutional
Andera Partners
CIK 0001757283
$176.9M
Reported AUM
7
Positions
Q1 2026
Period
2026-05-11
Filed
The Brief · Andera Partners · Q1 2026
AI · grounded in 13F
Andera Partners established a new position in AGMB valued at $16.1M. The fund also added new positions in NYXH for $1.5M and increased its stake in KMTS by 6.1%. These moves brought the fund's total position count to 7 with total AUM of $176.9M.
Portfolio · Q1 2026
Top holdings
QoQ vs Q4 2025
| # | Stock | Issuer | Price | Day % | 1Y Gr. | 5Y Gr. | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | KMTS | KESTRA MED TECHNOLOGIES LTD | $19.40 | -5.13% | -6.28% | -19.37% | $53.7M | 30.36% | +155,086 | +6.1% |
| 2 | EVMN | EVOMMUNE INC | $19.92 | -3.72% | 8.20% | 16.36% | $43.6M | 24.66% | — | HELD |
| 3 | MLYS | MINERALYS THERAPEUTICS INC | $23.69 | -5.43% | 46.96% | 51.28% | $43.1M | 24.38% | — | HELD |
| 4 | AGMB | AGOMAB THERAPEUTICS NV | $9.92 | -16.57% | -32.29% | -5.43% | $16.1M | 9.12% | +1,538,702 | NEW |
| 5 | IVA | INVENTIVA SA | $4.03 | -4.73% | 11.79% | -70.01% | $10.1M | 5.70% | — | HELD |
| 6 | ABVX | ABIVAX SA | $101.53 | -3.24% | 1139.68% | 900.30% | $8.7M | 4.92% | — | HELD |
| 7 | NYXH | NYXOAH S A | $1.45 | -49.65% | -81.10% | -95.53% | $1.5M | 0.86% | +522,057 | NEW |
Source: SEC EDGAR · accession 0001757283-26-000012. 13F discloses long positions only — shorts, foreign equities, and options are excluded.